Sec Form 4 Filing - DOYLE WILLIAM F @ Novocure Ltd - 2017-02-28

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
DOYLE WILLIAM F
2. Issuer Name and Ticker or Trading Symbol
Novocure Ltd [ NVCR]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director X __ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
Executive Chairman
(Last) (First) (Middle)
C/O NOVOCURE INC., 20 VALLEY STREAM PKWY, SUITE 300
3. Date of Earliest Transaction (MM/DD/YY)
02/28/2017
(Street)
MALVERN, PA19355
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__ X __ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 02/28/2017 M 686,836 A $ 3.59 19,822,874 ( 4 ) I WFD Ventures Fund II, L.P. ( 1 )
Ordinary Shares 02/28/2017 F( 2 ) 324,440 D $ 7.6 19,498,434 I WFD Ventures Fund II, L.P. ( 1 )
Ordinary Shares 02/28/2017 M 525,618 A $ 3.59 20,024,052 I WFD Ventures Fund II, L.P. ( 1 )
Ordinary Shares 02/28/2017 F( 3 ) 248,285 D $ 7.6 19,775,767 I WFD Ventures Fund II, L.P. ( 1 )
Ordinary Shares 84,699 ( 5 ) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Dispose d of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants $ 3.59 02/28/2017 M 686,836 ( 6 ) 07/31/2017 Ordinary Shares 686,836 $ 0 0 I WFD Ventures Fund II, L.P. ( 1 )
Warrants $ 3.59 02/28/2017 M 525,618 ( 6 ) 07/21/2018 Ordinary Shares 525,618 $ 0 0 I WFD Ventures Fund II, L.P. ( 1 )
Warrants $ 3.59 ( 6 ) 07/31/2017 Ordinary Shares 6,498 6,498 D
Warrants $ 3.59 ( 6 ) 07/21/2018 Ordinary Shares 3,879 3,879 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
DOYLE WILLIAM F
C/O NOVOCURE INC.
20 VALLEY STREAM PKWY, SUITE 300
MALVERN, PA19355
X X Executive Chairman
WFD Ventures Fund II, L.P.
C/O NOVOCURE INC.,
20 VALLEY STREAM PKWY SUITE 300
MALVERN, PA19355
X Director by Deputization
Signatures
By: /s/ William F. Doyle 03/02/2017
Signature of Reporting Person Date
WFD Ventures Fund II, L.P., By: WFD-GP II, LLC, its general partner, By: WFD Ventures LLC, sole member of WFD-GP II LLC, By: /s/ William F.Doyle, Title: Managing Director 03/02/2017
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.
( 2 )Reflects 324,440 ordinary shares withheld by the issuer at the market price of $7.60 per share less an exercise price of $3.59 per share in connection with the cashless exercise of 362,396 warrants to purchase ordinary shares owned by WFD Ventures Fund II, L.P.
( 3 )Reflects 248,285 ordinary shares withheld by the issuer at the market price of $7.60 per share less an exercise price of $3.59 per share in connection with the cashless exercise of 277,333 warrants to purchase ordinary shares owned by WFD Ventures Fund II, L.P.
( 4 )The Amendment filed on Form 4/A on February 21, 2017 incorrectly reflected the total number of ordinary shares beneficially owned by WFD Ventures Fund II, L.P. WFD Ventures Fund II, L.P. beneficially owned 19,136,038 ordinary shares following the transactions reported by the aforementioned Form 4/A.
( 5 )The Amendment filed on Form 4/A on February 21, 2017 incorrectly reflected the total number of ordinary shares beneficially owned by William F. Doyle. William F. Doyle beneficially owned 84,699 ordinary shares following the transactions reported by the aforementioned Form 4/A.
( 6 )Currently exercisable as of the date hereof.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.